Post-marketing safety surveillance of ado-trastuzumab emtansine: a real-world data retrospective cohort study using disproportionality analysis
This analysis offers the most comprehensive overview of ado-trastuzumab emtansine induced hemorrhage to date, shedding new light on this severe complication. Understanding the underlying mechanisms of these positive PTs can provide useful insights for further research.
Authors
- Yujing Weng
- Yaowei Gan
- Endong Chen (ORCID: https://orcid.org/0000-0003-3685-9258)
- Chen Chen (ORCID: https://orcid.org/0009-0009-3940-1569)
- Yingying Chen (ORCID: https://orcid.org/0000-0002-5049-8092)
- Yefeng Cai (ORCID: https://orcid.org/0000-0002-0277-4080)
- Qingxuan Wang (ORCID: https://orcid.org/0000-0003-4258-0966)
- Bowen Zhang
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1080/14740338.2024.2438748
- Citations
- 1
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Health Commission of Zhejiang Province